Your Location:
Home >
Browse articles >
Renshentang Alleviates Atherosclerosis in Mice by Targeting TRPV1 to Regulate Foam Cell Cholesterol Metabolism
Updated:2025-08-04
    • Renshentang Alleviates Atherosclerosis in Mice by Targeting TRPV1 to Regulate Foam Cell Cholesterol Metabolism

    • YUAN Yulu , CHU Ce , TAO Xuguang , YANG Zhen , CHEN Xiangyun , HE Zhanzhan , XU Yongqi , ZHANG Yuxin , ZHAO Peizhang , CHEN Wanping , ZHAO Hongxia , WANG Wenlai
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 17, Pages: 11-19(2025)
    • DOI: 10.13422/j.cnki.syfjx.20250903     

      CLC:
    • Accepted:03 June 2025

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 8 ) Tabs( 7 )

  • References

  • Publication Info

  • Metrics

284

Views

343

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Mechanisms of Renshentang in Treating AS via Regulation of Endothelial Cell Inflammation Based on TRPV1
Effect of Huayu Qutan Recipe and its Separated Recipes on Cholesterol Metabolism in HepG2 Cells
Iron Homeostasis Imbalance Promotes Atherosclerosis and Therapeutic Mechanisms of Traditional Chinese Medicine
Key Issues and Research Ideas of Traditional Chinese Medicine Anti-aging Guided by Essence-Qi-spirit Theory of Qiluo Doctrine
Clinical and Mechanistic Research Progress on Classical Traditional Chinese Medicine Formulas in Treatment of Chronic Heart Failure

Related Author

CHU Ce
YUAN Yulu
TAO Xuguang
HE Zhanzhan
ZHANG Yuxin
XU Yongqi
CHEN Wanping
WANG Wenlai

Related Institution

Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences
Lanxi Hospital of Traditional Chinese Medicine
Lanxi Traditional Chinese Medicine Hospital
West China Clinical Medical College, Sichuan University
Liaoning University of Traditional Chinese Medicine